Clinical Outcomes of Next-Generation Chimeric Antigen Receptor T-Cell Therapy in Acute Lymphoblastic Leukemia
Objective: To evaluate efficacy, durability, and safety of next-generation chimeric antigen receptor T-cell therapies in relapsed or refractory acute lymphoblas…